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It has been rather rare within the last few years in the 
medical literature to come across a study that deals with 
basic methodology for evaluation of global plus regional lefi 
ventricular wall motion behavior. Such techniques were 
developed, substantiated and then accepted for general 
clinical use a number of years ago and both invasive and 
noninvasive options abound. This is not true for the right 
ventricle, primarily because the right ventricle lacks the 
fairly simple structural geometry of the left ventricle (which 
permits a rather straightforward analytic evaluation). This 
partial neglect is most certainly also due to the long-standing 
belief that the right ventricle is a relatively unimportant part 
of the human cardiovascular system, and that, therefore, the 
greatest amount of attention should be devoted to its left- 
sided counterpart. When the problem of geometry was 
mostly resolved through the discovery of new invasive and 
noninvasive analytic approaches, and as it became clear that 
the right ventricle is a very important entity, more frequently 
involved in more disease states than was previously sus- 
pected and often determining whether the patient will sur- 
vive, various methodologies for right ventricular perform- 
ance analysis began to proliferate with alacrity and started to 
catch up with similar techniques defined and accepted for the 
left ventricle over a decade and a half ago. 
Right ventricular infarction. In this issue of the Journal, 
Ratner et al. (1) propose yet another approach for the right 
ventricular performance assay. Their technique is noninva- 
sive and employs radiotracers. Beyond the global right 
ventricular performance assessment, however, which here- 
tofore was as far as the radionuclide techniques would take 
us, this study now also advances a much needed regional 
right ventricular wall motion survey. That such a noninva- 
sive combination of global and regional assays for right 
ventricular performance is very much needed becomes clear 
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if one just briefly reviews the newest findings emanating 
from right ventricular performance research. It is by now 
firmly established that significant right ventricular involve- 
ment is much more common in ischemic heart disease than 
originally believed; a recent prospective study on >lOO 
consecutive autopsies found that right ventricular infarction 
was present in 84% of the cases; there was even a 3% 
incidence rate of isolated right ventricular infarction (2). 
Furthermore, the right ventricle was involved with equal 
frequency in anterior and inferior myocardial infarction, but 
inferior right ventricular infarcts were much larger (in- 
volving, on the average, 15% of the right ventricular wall). 
We now also know that such extensive right ventricular 
injury is characterized by augmented peaks of released 
creatine kinase, so that after inferior infarction, cardiac 
enzymes frequently do not accurately reflect the extent of 
damage to the left ventricle because the substantial portion 
of the released enzymes comes from the right ventricle (3). 
When such right ventricular infarction is, therefore, clini- 
cally suspected, it is often prudent to perform a rather 
detailed (preferably noninvasive) evaluation of the right 
ventricular performance: a failure to do so-and to thereby 
miss a large right ventricular infarct-can carry a grim 
prognosis. Thus, accurate noninvasive right ventricular im- 
ages acquired after a significant right ventricular infarction 
will often depict profound right ventricular dysfunction 
associated with high morbidity and mortality (4). In addition, 
such evidence for extensive right ventricular infarction not 
only is associated with these frequent serious complications, 
but also provides a very important clinical warning: when 
right ventricular infarction causes the low output syndrome, 
this status rarely improves with volume expansion alone: 
additional pharmacologic or mechanical assist interventions, 
or both, often become necessary (5). 
The predictive value of right heart ventriculography ex- 
tends to patients whose coronary artery disease is so ad- 
vanced as to cause congestive heart failure: in patients 
whose right ventricular ejection fraction (determined by 
radionuclide ventriculography) was <35%, the mortality was 
three times greater than that among patients with a healthier 
right ventricle (6). These findings were subsequently con- 
firmed in a similar study of patients with heart failure after an 
acute myocardial infarction; a depressed right ventricular 
ejection fraction (in patients with concomitantly depressed 
left ventricular ejection fraction) was still an independent 
predictor of increased mortality (7). Conversely, when a 
depressed right ventricle is successfully “resuscitated” by 
recanalizing its infarct-related vessel with thrombolytic ther- 
apy, there is often a swift improvement of heretofore com- 
promised right ventricular performance (8). It is tempting to 
postulate, jointly with the authors of Reference 8, that in 
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patients with an occlusion that cannot be lysed, right ven- 
tricular infarction occasionally results in irreversible cardio- 
genie shock despite adequate left ventricular performance. 
Right ventricular cardiomyopathy. If one is to believe a 
recent report from Italy (9), right ventricular cardiomyopa- 
thy causing sudden death in young people may be much 
more common than we used to think. This entity, also 
known as arrhythmogenic right ventricular dysplasia, is 
associated with generalized and regional cineangiographic 
right ventricular wall motion abnormalities (10). Delineation 
of right ventricular problems in otherwise often relatively 
asymptomatic people with this condition is obviously crucial 
if a serious attempt is to be made to prevent a frequently fatal 
outcome (I 1). Because this disorder presumably has a famil- 
ial predisposition (12) all members with genetic ties to such 
patients should be studied with appropriate right ventricular 
imaging techniques in an attempt to identify those who 
appear to be potential candidates for an active, often lethal 
form of this disease. 
Evaluation of right ventricular performance. As the prog- 
nosis for many other disorders is now also known to be 
greatly influenced by right ventricular performance, careful 
right ventricular imaging studies within such settings are 
often indicated. Exercise radionuclide right ventricular angi- 
ography has been shown to have a significant clinical prog- 
nostic value in patients with mitral stenosis (13); similar 
studies in patients with mitral regurgitation have revealed 
not only that the nonoperated patients with a right ventric- 
ular ejection fraction 530% die frequently, but that there is 
an obvious trend toward improved survival in patients with 
depressed right ventricular ejection fraction who undergo 
surgery (14). It is well known that right ventricular perform- 
ance begins to deteriorate even with moderate increases in 
pulmonary pressures (1.5). When such elevated pulmonary 
pressures are associated with acute pulmonary emboliza- 
tion, the imaging of the right ventricle reveals right ventric- 
ular dysfunction and dilation. tricuspid regurgitation and 
abnormal septal position (16). It is of great interest, there- 
fore, that this very abnormal right ventricular portrait re- 
verses toward normal after treatment of emboli with intra- 
venous recombinant tissue-type plasminogen activator 
@t-PA), illustrating not only the potential usefulness of rt-PA 
in patients with pulmonary embolism that is causing serious 
hemodynamic compromise, but also the effectiveness with 
which appropriate serial right ventricular imaging studies 
reflect the changes in clinical status. 
Right ventricular ejection fraction. A major contribution 
of the right ventricular imaging proposed in the present 
report of Ratner et al. (1) is its ability not to underestimate 
the right ventricular ejection fraction. From the very brief 
overview given here, it is clear that this most commonly 
used index of right ventricular performance often acts as an 
accurate predictor of who will live and who will die: to 
inappropriately saddle a patient with even a hint that he or 
she may have a poor prognosis-because of an inaccurate 
right ventricular imaging study-is a terrible error. We 
showed years ago (17) that the normal mean right ventricular 
ejection fraction in adults (evaluated by biplane or single 
plane right ventricular cineangiography) is >60%. Similar 
values were subsequently reported in many other adult right 
ventricular cineangiographic studies; a very recent elegant 
right ventricular biplane cineangiographic investigation (18) 
with simultaneous micromanometer pressure measurements 
from the right ventricle again found the normal mean right 
ventricular ejection fraction to be 62%. Even though essen- 
tially all investigators working with radiotracers accept the 
premise that biplane right ventricular cineangiography rep- 
resents the reference standard, in the past, reported 
“normal” scintigraphic right ventricular ejection fraction 
values were nevertheless as a rule a full 10% (and, at times, 
even 20%) lower than the cineangiographic criteria. It was 
not until the definitive radiotracer study by Marving et al. 
(19). who used carefully designed dual first pass time-activity 
radiotracer curves generated from the end-diastolic and 
end-systolic regions, that scintigraphic right ventricular ejec- 
tion fraction values were found to be equal to left ventricular 
values (mean 65% and 66%, respectively). On the basis of 
their findings. Marving et al. (19) evoked a very important 
clinical implication: because the right and left ventricular 
ejection fractions are almost equal in normal subjects, diver- 
gences between them of, perhaps, ~10% might be an indi- 
cation of incipient cardiac disease evetz if both ventricles 
were still functioning within a commonly accepted normal 
range of ejection fraction. The present report by Ratner et al. 
(1) of yet another (and different) radionuclide technique now 
confirms many of the aforementioned findings and intro- 
duces additional order into this area. 
The present study. Beyond this valuable contribution, the 
study of Ratner et al. (I) introduces another analytic ap- 
proach that has heretofore not been a feature of radionuclide 
right ventricular investigations. Regionul right ventricular 
contraction abnormalities are now analyzed in normal sub- 
jects, patients with coronary artery disease and those with 
dilated cardiomyopathy. Only a very few invasive right 
ventricular cineangiographic studies have addressed this 
important phenomenon; it is good to see that we can now 
acquire similar valuable data noninvasively. The report of 
Ratner et al. (I) would have been stronger yet had they 
performed prospective intra- and interobserver variability 
assessments, but they should be commended for going back 
retrospectively to the original data in an attempt to deter- 
mine reproducibility of their observations. It would also 
have been preferable if the right ventricular radionuclide 
studies in their patients with coronary artery disease had 
been uniformly done much sooner after the onset of an acute 
myocardial infarction (rather than stretched out over an 18 
day period). It is well known that the right ventricle can 
often recover quite quickly after an acute ischemic injury 
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(20); one thus wonders not only if the right ventricular 
ejection fractions would have been lower, but also if the 
regional right ventricular contractile abnormalities would 
have been more frequent had the patients been studied 
within the first 24 h after an acute myocardial infarction. 
Obviously, however, the immediate experimental studies are 
often not feasible in an acutely ill patient. 
It is rewarding to see that we are getting to be quite 
sophisticated in our investigative attempts to better under- 
stand the right ventricle. Although we will begin to thor- 
oughly unravel many subtle right ventricular pathophys- 
iologic performance modifications only when the two 
ventricles can be jointly analyzed with very sensitive and 
accurate techniques (21), we have come a long way from 
very humble beginnings, New indications for right ventricu- 
lar evaluation seem to be emerging almost daily; one can 
only hope that the test of time will show that selecting and 
using at least some of them can make the difference by 
favorably influencing both the immediate clinical course and 
the eventual long-term prognosis. 
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